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The superfamily of two pore-domain K + (K 2P ) channels has a least 15 members 1 , of which mainly TASK1 is expressed in cardiac myocytes. TASK1 gating is voltage independent, but the channel is acid sensitive, being activated by alkalotic conditions. Ion currents carried by TASK1 likely contribute to the cardiac action potential duration (APD), and pharmacological inhibition of TASK1 lengthens the APD 2,3 while TASK1 knock-out animals display a long QT on the electrocardiogram 4, 5 . Interest in TASK1 channels has been mounting, because their activity in various cell types seems critical for several physiological processes while their changed expression and/or function may underlie many disease conditions. The channels are potential targets for diverse therapeutic actions, including antiarrhythmic, antihypertensive, antiepileptic and antidepressive treatments as well as analgesia and inhalation anesthesia 6 . Therefore, identifying the signaling pathways involved in their regulation is important. Newly available investigation tools, such as those used in the study of . However, the PKC phosphorylation site is located in a nonconserved region of TASK1, leaving the possibility that TASK1 in cardiomyocytes of other species may respond differently. In the study of Schiekel et al. 7 an involvement of PKC is excluded in the endothelin-1 effects, which were insensitive to PKC inhibitors.
Having ruled out roles for IP 3 Obviously, other mechanisms have to be invoked for the endothelin-1 inhibition on cardiac TASK1, including 1) a direct action of PLC itself, 2) a PKC-independent effect of DAG or, as suggested by Schiekel et al. . A possible direct effect of DAG on cardiac TASK1 has not been tested, but in carotid body cells, where the channel may be involved in detecting hypoxia, oleoyl-acetylglycerol, a DAG analogue, had no effect in the presence of PKC inhibitors, making it unlikely that the lipid can directly inhibit TASK1 14 . Similarly, DAG failed to inhibit neuronal TASK channels 13 . The only remaining possibility is that of an involvement of DAG metabolites. It is of interest to note that arachidonoyl-ethanolamide, also called anandamide, which can be derived from membrane phospholipids (Fig. 1) by the action of a PLC 15, 16 , is an inhibitor of TASK1.
Anandamide is an endogenous cannabinoid but its effects on TASK1 are independent of cannabinoid receptors. 2-Arachidonoyl-glycerol, another endogenous cannabinoid structurally very close to anandamide, can be produced from DAG by a DAG lipase (Fig. 1 , which likely plays a role in the remodeling process associated with hypertrophy.
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